Chloramphenicol 1% - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

chlorsig 1% chloramphenicol 10 mg/g eye ointment tube

aspen pharma pty ltd - chloramphenicol, quantity: 10 mg/g - eye ointment - excipient ingredients: wool fat; liquid paraffin; white soft paraffin - indications as at 29 january 2001: for the treatment of bacterial conjunctivitis and other superficial ocular infections caused by chloramphenicol-sensitive organisms.

Canada - English - Health Canada

chloramphenicol ointment

pharma stulln inc. - chloramphenicol - ointment - 1% - chloramphenicol 1% - antibacterials

Canada - English - Health Canada

chloramphenicol solution

pharma stulln inc. - chloramphenicol - solution - 0.5% - chloramphenicol 0.5% - antibacterials

United States - English - NLM (National Library of Medicine)

viceton chloramphenicol tablet coated

osborn - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 1 g

United States - English - NLM (National Library of Medicine)

viceton- chloramphenicol tablet, coated

bimeda, inc. - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 250 mg - indications : chloramphenicol tablets are recommended for oral treatment of the following conditions in dogs: - bacterial pulmonary infections caused by susceptible microorganisms such as: staphylococcus aureus , streptococcus pyogenes and brucella bronchiseptica . - infections of the urinary tract caused by susceptible microorganisms such as: escherichia coli , proteus vulgaris , corynebacterium renale , streptococcus spp., and hemolytic staphylococcus . - enteritis caused by susceptible microorganisms such as: e. coli , proteus spp., salmonella spp., and pseudomonas spp. - infections associated with canine distemper caused by susceptible microorganisms such as: b. bronchiseptica , e. coli , p. aeruginosa , proteus spp., shigella spp. and neisseria catarrhalis . additional adjunctive therapy should be used when indicated. most susceptible infectious disease organisms will respond to chloramphenicol therapy in three to five days when the recommended dosage regimen is followed. if no response to chloram